CD5789

· MD Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CD5789, covering 2016-04-13 to 2021-09-20. Get the full timeline:

Most recent: Clinical Trial Update: Dose Range Study of CD5789 in Acne Vulgaris [Phase 2]